Eye Care News

Scientists have uncovered a potential new strategy for treating eye diseases that affect millions of people around the world, often resulting in blindness.

A breakthrough study results in the restoration of retinal and visual functions of mice models suffering from inherited retinal disease.

Autopsy, airway suctioning and cardiopulmonary resuscitation are among the list of medical procedures that pose a risk of spreading COVID-19 from a patient to their health-care provider by creating aerosols, according to new research.

Working with fish, birds and mice, researchers report new evidence that some animals’ natural capacity to regrow neurons is not missing, but is instead inactivated in mammals.

Researchers reveal how subanesthetic ketamine, which is used for pain management and as an antidepressant in humans, is effective in treating adult amblyopia, a brain disorder commonly known as ‘lazy eye.’

This retrospective analysis aimed to quantitatively characterize aggressive posterior retinopathy of prematurity in a large cohort.

Researchers assessed the long-term outcomes of uveitic glaucoma in eyes undergoing systemic therapy or fluocinolone acetonide implant.

This week, the second-generation Kahook Dual Blade is set to hit U.S. markets, pegcetacoplan appears to slow geographic atrophy and a new light-sensing protein offers hope for people with degenerative retinal diseases.

Investigators measured macular thickness changes after lens removal and anterior vitrectomy for cataract in pediatric eyes.

Jeffrey Goldberg, MD, PhD, Blumenkranz Smead professor and chair of ophthalmology at Stanford University, has been elected to the National Academy of Medicine.